Patient Education Kit
The new ARALAST Patient Education Kit is designed to help people living with AAT deficiency*. Baxter is pleased to provide this packet of useful information about the diagnosis, treatment, and management of this condition as another service to the Alpha-1 community.
*Also known as Alpha-1, alpha-1 antitrypsin deficiency, AATD, A1-PI deficiency, alpha-1 antiprotease deficiency, A1AD, or hereditary or genetic emphysema.
In the kit, you will find a wealth of print materials to help you with all aspects of living with Alpha-1, including these booklets:
- Getting Started with Augmentation Therapy
- About Alpha1-Antitrypsin (AAT) Deficiency
- Reimbursement Q & A
- The ARA-ASSIST Program
Plus, the kit includes a Health Diary and a CD of relaxation music.
You may order a Patient Education Kit online or by phone at 1-866-ARALAST (272-5278).
ARALAST [Alpha1-Proteinase Inhibitor (Human)] is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.
Please review the Important Safety Information and the Full Prescribing Information
| To view PDF, you will need Adobe® Acrobat® Reader® software. |

